Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass

PHASE3RecruitingINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

February 14, 2020

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2028

Conditions
Congenital Heart Disease in ChildrenNeuroprotection
Interventions
DRUG

Allopurinol

Allopurinol powder for solution for infusion (PFI) 20 mg/kg body weight per administration will be administered early postnatally (within 45 minutes and 12 hours after the first dose), preoperatively (12 hours before surgery), intraoperatively (during surgery) and postoperatively (24 hours after surgery) to the neonate in case of a prenatal CCHD diagnosis. Allopurinol PFI will be administered only pre-, intra- and postoperatively to the neonate in case of a postnatal CCHD diagnosis.

DRUG

Mannitol

Mannitol powder for solution (PFI) placebo will be administered early postnatally (within 45 minutes and 12 hours after birth), preoperatively (12 hours before surgery), intraoperatively (during surgery), and postoperatively (24 hours after surgery) to the neonate in case of a prenatal CCHD diagnosis. Mannitol PFI-placebo will be administered only pre-, intra- and postoperatively to the neonate in case of a postnatal CCHD diagnosis.

Trial Locations (4)

9700 RB

RECRUITING

University Medical Center Groningen (UMCG), Groningen

6525 GA

ACTIVE_NOT_RECRUITING

Radboud University Medical Center Nijmegen (Radboudumc), Nijmegen

3015 GD

RECRUITING

Erasmus Medical Center Rotterdam (Erasmus MC), Rotterdam

3584 EA

RECRUITING

University Medical Center Utrecht (UMC Utrecht), Utrecht

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

University Medical Center Groningen

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

University Medical Center Nijmegen

OTHER

collaborator

ACE Pharmaceuticals BV

OTHER

lead

dr. M.J.N.L. Benders

OTHER